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    Twenty－seveh patients with advanced urogenital cancer， 14 ptostatic adenocarcinoma， 5 urinary
bladder cancer，3non－sernino1皿atous testicular cancer， l prostatic transitional cell carcinorna，1urcthral
squamous cell carcinoma， 1 Wilms’ tumor， 1 renal cell carcinoma， 1 penile cancer were treated with
cis－diamminedichloroplatinum （II） （CDDP）．
    Of 14 prostatic adenocarcinoma， 7 cases were received CDDP single treatment and 7 cases were
re6eiVed CDDP coinbined ’treatment with bil． orchiectomy， diethylstilbestrol diphosphate， futraful
and pi6ibanylL Complete response ivvas ndt obServed， but partial responses were observed in 4 cases
in single treatment group and 3”cases in combined treatment group． Overall response rate was 500／．
in advanced prostatic cancers with CDDP treatment， and response rate was 570／o with single treatment
and 430／， with combined treatment． Of 7 cases with CDDP single treatment， however， 5 cases had
bee’n receiy．ed bil． orchiectorny． previously， so that response rate was 580／． ip the patients group with
bil． orchiectomy， and no objecti〈re response was observed in 2 patients without bil． orchiectomy．
   Non－seminomatous testicular cancers well responsed to Einhorn’s PVB regimen， CDDP， vinblastine
and bleomycin． Complete responses were achieved in 2 patientS with retroperitoneal lymphadnectomy
followed．by CDDP combined treatment， and partial response was observed in a patient whosc multip｝e
bulky lung metastasis regressed remarkably， by 2 courses of CDDP combined treatment． The pa－
tient died of cancer 13 months after the CDDP treatment．
   Urinai’v． bladder cancers r．esponsed to CDDP single ．treatment． Complete response was not
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置bserved， but partial response was in all 5 cases． Prostatic transitional cell carcinoma was achieved
complete rosponse with CDDP single treatment．
  Wilms’ tumor with local recurrence， liver and lung metastasis also responsed to CDDP with vin－
blastine． However， penile cancer， urethral squarnous cell carcinoma and renal cell carcinoma did
not response to CDDP treatment．
  In a view of the toxicity， moderate to severe nausea， vomiting and anorexia were observed in
all cases during CDDP treatment and following several days． Nephrotoxity was mild in 4 cases and
moderate in a case． Anemia was observed in 19 cases （700／o）， and leucopenia was observed in 8 cases
（〈3000） and 7 cases （〈2000）． ln this study group， a prostatic cancer patient with liver and extensive
bony metastasis died of severe pancytopenia． Peripheral neuropathy， muscle pain and alopecia were
observed in all 4 cases treated with vinblastine and CDDP， but alopecia and muscle pain were not
observed in other CDDP treatment， and mild peripheral neuropathy was observed in a patient treated
without vinblastine． Azospermia was observed in a case treated with PVB regimen， and he was only
a case who underwent semen examination．
  At present， we believe CDDP is one of the most promising chemotherapeutic agent for manage－
ment of advanced urogenital cancers．
Key words ： Advanced urogenital cancers， cis－Diamminedichloroplatingm

















































X線像，IVP，超音波診断法， CT scan， RIシンチグ
ラムにより病巣部の観察を行なった．化学療法による
Table 1． Patient characteristic and subsequnce of CDDP treatmeht
caseage sexdiseasestage（TNM） grade Pr or Rei
 treatment





























































































































































































































































































































































1）： primary ot icecurrence 2）： CBDP sangle
5）； myocardial infarction
or combined treatment 3）： total CDDP rngfm2 4）： pancytopeni a
abberjviation used ： P＝prostate，B＝bladder，T＝testis，R＝kidney， HM＝horinonal manipulation
RAD＝radietherapy，T－Cx＝total cystectQmy，P－Cx＝partial cystectomy，Orchx＝orchiectomy，Lx＝lymphadenectomy
Nx＝nephrectomy，T－Penx＝total penectomy，PV＝provera，CD＝cancer death，OD＝other disease death．8
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Table 2． Modality of CDDP administration
1） Dextran一一40， 250－500m1
2） 20％ mannitol 100ml－200m1
3） GlucQse Ringer’s solution 500m1
10％ Nacl 20ml， furosemide 10mg
20％ mannitol 50ml， CDDP IOmg／m2
4） Same as above
5） Glucose Ringer’s solution 500ml
  10％ Nacl 20m1
6） 20％ mannitol leO－200ml
ア） Glucose Ringer，s solution 500ml
  10％ Nacl 20ml
Infusion time ： more than 6 hours．
抗腫瘍効果判定には斎藤・小山班の分類を用いた2）．
すなわち著効（complete response， CR），有効（Par－















































































  A） before CDDP treatment B） after 3 courses of anDP                              combined chemotherapy
































































  A） before treatment
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      A） before treatment B） after 4 courses of CDDP treatment





































































     moderate＊
Anemia（くHb，10g／dl）
Leucopenia（く3000）
























































































  A） before treatment B） after 4 courses of CDDP treatment
Bone scan of a patient （case 20） with pubic bony metastasis of urinary bladder adenocarcinoma
Fig． 5． Clinical course of a patient （case 25） with Wilms’ tumor treated with CDDP combined chemotherapy．
Clinical course
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ではFig・4－Aに示すように恥骨部にRI異常集積像


































































































 鋼㌔叩   麟
    B） after 4 courses of CDDP combined chemotherapy
Fig． 6． Chest X－P of a patient （case 25） with lung metastasis
      of Wilms’ tumor
A） before treatment
B） after 4 courses of CDDP combined chemotherapy
Fig． 7． Chest CT scan of a patient （case 25） with lung
























































たが，Al－P， Ac－P， PAPはおのおの56・3→202・5 KA，
653→420KA，623→385 KAとほとんど変化がなく，
CDDP 3コース終了後に二二術を施行し， diethylsti－















































































































Fig． 8． Clinical course of a patient with advanced prostatic carcinoma
    treated with CDDP single．
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B） after 2 courses of CDDP treatment
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